Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481663
Status:
COMPLETED
Last Update Posted:
2017-04-04
First Post:
2007-06-01
Brief Title:
A Study of Different Doses of Sitagliptin MK-0431 in Participants With Type 2 Diabetes Mellitus MK-0431-014
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2004-07-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-05-14
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-01
First Submit QC Date:
June 1 2007
Study First Post Date:
2007-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-31
Last Update Post Date:
2017-04-04
Last Update Post Date Type:
ACTUAL